Avita Medical | 1811094D - Cost Of Sales

Stock Price
1.09
Daily Change
-0.05 -3.96%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.06

Avita Medical reported AUD3.47M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Celltrion KRW 402.86B 14.24B Sep/2025
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Cochlear AUD 158.85M 131.25M Jun/2025
CSL USD 1.79B 2.15B Jun/2025
Cspc Pharmaceutical CNY 2.28B 25.27M Sep/2025
Divis Laboratories Ltd INR 11.86B 1.18B Sep/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Medical Developments International AUD 2.18M 3.09M Jun/2025
Nanosonics AUD 23.12M 2.97M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Pharma Mar EUR 2.3M 477K Sep/2025
Polynovo AUD 4.77M 2.77M Jun/2024
Qiagen NV USD 187.78M 11.47M Sep/2025
Ramsay Health Care AUD 2.98B 742.1M Jun/2025
ResMed USD 536.28M 21.52M Dec/2025
Sartorius EUR 450M 18.1M Sep/2025
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024
Tilray USD 164.37M 8.41M Sep/2025
Zz Pientze Pharmaceu CNY 1.34B 601.08M Sep/2025